<div dir="ltr">Dear Ali,<div><br></div><div>Could you give me the information for the source of BCG used and also the protocol for preparing materials for the leishmanin test ? I recall the materials are either Leishmania promastigotes or Crithidia preserved in 1% phenol ? I could be totally wrong. I don't remember the species and cell density or number, etc. Also, the volume and site of injection...........</div>
<div><br></div><div>Thank you in advance for your consideration of these requests.</div><div><br></div><div>KP</div></div><div class="gmail_extra"><br><br><div class="gmail_quote">On Fri, Jan 10, 2014 at 8:47 AM, Ali Khamesipour <span dir="ltr"><<a href="mailto:khamesipour_ali@yahoo.com" target="_blank">khamesipour_ali@yahoo.com</a>></span> wrote:<br>
<blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div><div style="font-size:12pt;font-family:HelveticaNeue,Helvetica Neue,Helvetica,Arial,Lucida Grande,sans-serif">Dear All,<br>
Dr Modabber you should well remember that in the trials in Iran we had a degree of LST conversion in individuals who were originally LST negative (no response to leishmanin; no induration and no erythema), the control group received BCG, and a percent of them converted to LST positive.<br>
All the best Ali <br><div><span><br></span></div><div> </div><div>Dr Ali Khamesipour</div><div style="display:block"> <br> <br> <div style="font-family:HelveticaNeue,Helvetica Neue,Helvetica,Arial,Lucida Grande,sans-serif;font-size:12pt">
<div style="font-family:HelveticaNeue,Helvetica Neue,Helvetica,Arial,Lucida Grande,sans-serif;font-size:12pt"> <div dir="ltr"> <font face="Arial"> On Friday, January 10, 2014 11:22 AM, Farrokh Modabber
<<a href="mailto:fmodabber@dndi.org" target="_blank">fmodabber@dndi.org</a>> wrote:<br> </font> </div> <div><div>
<div>
<div>
<div>Dear Colleagues,</div>
<div>I recall from Prof. Mayrinks studies, that BCG vaccination may convert leishmanin skin test in some volunteers who are LST-negative (MST-negative). The reactivity would gradually diminish after a few months. Would appreciate any information
on that and on Prof. Mayrink’s current email address.</div>
<div>Many thanks,</div>
<div>Farrokh Modabber</div>
</div>
<br><br>--<br>
<i> This email was sent by <a href="http://icb.usp.br" target="_blank">icb.usp.br</a> </i>
­­ </div>
</div><br>_______________________________________________<br>Leish-l mailing list<br><a href="mailto:Leish-l@lineu.icb.usp.br" target="_blank">Leish-l@lineu.icb.usp.br</a><br><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" target="_blank">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><br>
<br>--<br>This email was sent by <a href="http://icb.usp.br" target="_blank">icb.usp.br</a><br><br><br></div> </div> </div> </div> </div><br><br>--<br>
<i> This email was sent by <a href="http://icb.usp.br" target="_blank">icb.usp.br</a> </i>
­­ </div><br>_______________________________________________<br>
Leish-l mailing list<br>
<a href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><br>
<a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" target="_blank">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><br>
<br>
--<br>
This email was sent by <a href="http://icb.usp.br" target="_blank">icb.usp.br</a><br>
<br></blockquote></div><br></div>